| Dr Ari Jay Namon, MD | |
|
30 Columbia St, Poughkeepsie, NY 12601-3906 | |
| (845) 231-5600 | |
| (845) 592-7705 |
| Full Name | Dr Ari Jay Namon |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 38 Years |
| Location | 30 Columbia St, Poughkeepsie, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700975372 | NPI | - | NPPES |
| 001349473 | Medicaid | CT | |
| 110039589A | Medicaid | MA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Charlotte Hungerford Hospital | Torrington, CT | Hospital |
| Sharon Hospital | Sharon, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Charlotte Hungerford Hospital | 4486557501 | 159 |
News Archive
A new system for delivering a drug to organ transplant patients, which could avoid the risk of harmful side effects, is being developed by scientists at the University of Strathclyde in Glasgow.
A pensioner has used his chronic illness to create a digital platform that could save health services millions of pounds and make a huge difference to patients' lives.
The Portico IDE study found that 30-day safety and one-year effectiveness outcomes of a novel self-expanding transcatheter aortic valve replacement (TAVR) system for patients with severe aortic stenosis (AS) at high or extreme-risk for surgery was noninferior to contemporary FDA-approved TAVR systems available in the United States.
Cromoz Inc., located in Research Triangle Park, will initiate water-soluble carbon nanotube-based cancer drug delivery system in Hyderabad, India. The water-soluble carbon nanotubes, which have functional groups on the walls that allows for conjugation with cancer drugs, was developed in partnership with the Indian Institute of Kanpur (ITT). The conjugated carbon nanotubes serves as a drug delivery vehicle with the ability to target the cancer site which has the potential to increase the drug efficacy.
Injections of botulinum toxin A (botox) into the prostate are a promising alternative treatment for the millions of men who have benign prostatic hyperplasia (BPH), a condition commonly referred to as enlarged prostate, according to a study conducted by the University of Pittsburgh School of Medicine and Chang Gung Memorial Hospital in Taiwan.
› Verified 8 days ago
| Entity Name | The Charlotte Hungerford Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629075734 PECOS PAC ID: 4486557501 Enrollment ID: O20040128000183 |
News Archive
A new system for delivering a drug to organ transplant patients, which could avoid the risk of harmful side effects, is being developed by scientists at the University of Strathclyde in Glasgow.
A pensioner has used his chronic illness to create a digital platform that could save health services millions of pounds and make a huge difference to patients' lives.
The Portico IDE study found that 30-day safety and one-year effectiveness outcomes of a novel self-expanding transcatheter aortic valve replacement (TAVR) system for patients with severe aortic stenosis (AS) at high or extreme-risk for surgery was noninferior to contemporary FDA-approved TAVR systems available in the United States.
Cromoz Inc., located in Research Triangle Park, will initiate water-soluble carbon nanotube-based cancer drug delivery system in Hyderabad, India. The water-soluble carbon nanotubes, which have functional groups on the walls that allows for conjugation with cancer drugs, was developed in partnership with the Indian Institute of Kanpur (ITT). The conjugated carbon nanotubes serves as a drug delivery vehicle with the ability to target the cancer site which has the potential to increase the drug efficacy.
Injections of botulinum toxin A (botox) into the prostate are a promising alternative treatment for the millions of men who have benign prostatic hyperplasia (BPH), a condition commonly referred to as enlarged prostate, according to a study conducted by the University of Pittsburgh School of Medicine and Chang Gung Memorial Hospital in Taiwan.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ari Jay Namon, MD 110 S Bedford Rd, Caremount Medical Pc, Mount Kisco, NY 10549-3446 Ph: (914) 241-1050 | Dr Ari Jay Namon, MD 30 Columbia St, Poughkeepsie, NY 12601-3906 Ph: (845) 231-5600 |
News Archive
A new system for delivering a drug to organ transplant patients, which could avoid the risk of harmful side effects, is being developed by scientists at the University of Strathclyde in Glasgow.
A pensioner has used his chronic illness to create a digital platform that could save health services millions of pounds and make a huge difference to patients' lives.
The Portico IDE study found that 30-day safety and one-year effectiveness outcomes of a novel self-expanding transcatheter aortic valve replacement (TAVR) system for patients with severe aortic stenosis (AS) at high or extreme-risk for surgery was noninferior to contemporary FDA-approved TAVR systems available in the United States.
Cromoz Inc., located in Research Triangle Park, will initiate water-soluble carbon nanotube-based cancer drug delivery system in Hyderabad, India. The water-soluble carbon nanotubes, which have functional groups on the walls that allows for conjugation with cancer drugs, was developed in partnership with the Indian Institute of Kanpur (ITT). The conjugated carbon nanotubes serves as a drug delivery vehicle with the ability to target the cancer site which has the potential to increase the drug efficacy.
Injections of botulinum toxin A (botox) into the prostate are a promising alternative treatment for the millions of men who have benign prostatic hyperplasia (BPH), a condition commonly referred to as enlarged prostate, according to a study conducted by the University of Pittsburgh School of Medicine and Chang Gung Memorial Hospital in Taiwan.
› Verified 8 days ago
James Edward Meltzer, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 102 Fulton Ave, Suite D, Poughkeepsie, NY 12603 Phone: 845-473-8600 Fax: 845-473-8654 | |
Dr. Rami N Payman, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 21 Reade Pl Ste 3200, Poughkeepsie, NY 12601 Phone: 845-471-4086 Fax: 845-471-8296 | |
Mark D Very, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 21 Reade Pl, 3rd Floor - Suite 3200, Poughkeepsie, NY 12601 Phone: 845-204-6125 Fax: 845-471-8296 | |
Dr. Ryan Seth Borress, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 21 Reade Pl Ste 3200, Poughkeepsie, NY 12601 Phone: 845-471-4086 Fax: 845-471-8296 | |
Dr. Manoj Timothy Abraham, M.D., F.A.C.S. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 82 N Water St, Poughkeepsie, NY 12601 Phone: 845-454-8025 Fax: 845-454-8026 | |
Dr. Arthur William Menken, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 35 Collegeview Ave, Poughkeepsie, NY 12603 Phone: 845-471-3580 Fax: 845-471-6378 |